ResearcherShanghai Jiao Tong UniversityNo recent work listed
Jiawei Chen
Matched on ORCID iD 0000-0002-0895-9027; OpenAlex author ID A5100362810. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper
Papers 6
- STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage. Co-author DOI 10.1016/j.intimp.2023.110709↗
- Inhibition of STAT3Y705 phosphorylation by Stattic suppresses proliferation and induces mitochondrial-dependent apoptosis in pancreatic cancer cells. Co-author DOI 10.1038/s41420-022-00922-9↗
- Periplocin Induces Apoptosis of Pancreatic Cancer Cells through Autophagy via the AMPK/mTOR Pathway. Co-author DOI 10.1155/2022/8055004↗
- Pharmacological Inhibition of STAT3 Attenuates Pancreatic Cancer Cell Invasion and Migration By Interacting with TGF-Β/Smad Signaling Co-author DOI 10.21203/rs.3.rs-1055773/v1↗
- Could Protons and Carbon Ions Be the Silver Bullets Against Pancreatic Cancer? First author DOI 10.3390/ijms21134767↗
- Potential involvement of IQGAP1 in proliferation and metastasis of human pancreatic cancer. Co-author DOI 10.2741/4442↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hangcheng Guo · 3 shared papers, 2021–2023 · strength 0.44
- Paper STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing o… DOI 10.1016/j.intimp.2023.110709↗
- Paper Inhibition of STAT3Y705 phosphorylation by Stattic suppresses proliferation and induces mitochondrial-dependent apoptos… DOI 10.1038/s41420-022-00922-9↗
- Paper Pharmacological Inhibition of STAT3 Attenuates Pancreatic Cancer Cell Invasion and Migration By Interacting with TGF-Β/… DOI 10.21203/rs.3.rs-1055773/v1↗
- Yongheng Bai · 3 shared papers, 2021–2023 · strength 0.44
- Paper STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing o… DOI 10.1016/j.intimp.2023.110709↗
- Paper Inhibition of STAT3Y705 phosphorylation by Stattic suppresses proliferation and induces mitochondrial-dependent apoptos… DOI 10.1038/s41420-022-00922-9↗
- Paper Pharmacological Inhibition of STAT3 Attenuates Pancreatic Cancer Cell Invasion and Migration By Interacting with TGF-Β/… DOI 10.21203/rs.3.rs-1055773/v1↗
- Yanyi Xiao · 2 shared papers, 2021–2022 · strength 0.26
- Paper Inhibition of STAT3Y705 phosphorylation by Stattic suppresses proliferation and induces mitochondrial-dependent apoptos… DOI 10.1038/s41420-022-00922-9↗
- Paper Pharmacological Inhibition of STAT3 Attenuates Pancreatic Cancer Cell Invasion and Migration By Interacting with TGF-Β/… DOI 10.21203/rs.3.rs-1055773/v1↗
- Qinbo Chen · 2 shared papers, 2021–2022 · strength 0.26
- Paper Inhibition of STAT3Y705 phosphorylation by Stattic suppresses proliferation and induces mitochondrial-dependent apoptos… DOI 10.1038/s41420-022-00922-9↗
- Paper Pharmacological Inhibition of STAT3 Attenuates Pancreatic Cancer Cell Invasion and Migration By Interacting with TGF-Β/… DOI 10.21203/rs.3.rs-1055773/v1↗
- Qiyu Zhang · 2 shared papers, 2021–2022 · strength 0.26
- Paper Inhibition of STAT3Y705 phosphorylation by Stattic suppresses proliferation and induces mitochondrial-dependent apoptos… DOI 10.1038/s41420-022-00922-9↗
- Paper Pharmacological Inhibition of STAT3 Attenuates Pancreatic Cancer Cell Invasion and Migration By Interacting with TGF-Β/… DOI 10.21203/rs.3.rs-1055773/v1↗
- Yangyang Guo · 1 shared paper, 2023 · strength 0.18
- Gangyin Xie · 1 shared paper, 2022 · strength 0.16
- Bicheng Chen · 1 shared paper, 2022 · strength 0.16
- Lihong Yang · 1 shared paper, 2022 · strength 0.16
- Hewei Zhang · 1 shared paper, 2022 · strength 0.16
- Anne-Catherine Wéra · 1 shared paper, 2020 · strength 0.15
- Camille Huart · 1 shared paper, 2020 · strength 0.15
- Benjamin Le Calvé · 1 shared paper, 2020 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.